It’s possible that the plasma of recovered COVID-19 patients may have antibodies that could help in the treatment of others with COVID-19.
Virtual Mini-Hack to address problems amplified by COVID-19
Nurses and other participants from a range of disciplines will work in teams to devise answers, develop prototypes and pitch solutions.
Rapid genome testing for infants saves lives, costs
A recently completed pilot program at CHOC and other California clinical sites helped target a baby’s specific genetic disease in just days.
The forefront of CAR T-Cell immunotherapy research for high-risk pediatric leukemia patients
Along with providing access to clinical trials for CAR T-cell therapy and other immunotherapy, CHOC is a certified KYMRIAH treatment center.
CHOC, University Lab Partners establish unique training program for the next generation of biotech innovators
A joint effort from CHOC and ULP is aimed at inspiring Orange County high school students to become the next generation of biotech innovators.
CHOC study shows reduced risk of emergency department COVID-19 infection
Asymptomatic healthcare workers in a community with a low COVID-19 prevalence who undergo daily screenings are unlikely to be carriers.
